Identifying the First Sleep-Related Genes

For this article, Jennifer Fisher Wilson interviewed Emmanuel Mignot, Center for Narcolepsy, department of psychiatry, Stanford University School of Medicine, in Stanford, Calif., and Masashi Yanagisawa, Howard Hughes Medical Institute investigator, department of molecular genetics, University of Texas Southwestern Medical Center at Dallas. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age.

Written byJennifer Fisher Wilson
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Narcolepsy has long fascinated sleep researchers because it is the only known neurological disorder that affects the generation and organization of sleep. In 1999, scientists of these Hot Papers identified the genes that cause narcolepsy, opening the door to understanding sleep at a molecular level. The findings marked the first time that a sleep gene was isolated, and led directly to understanding narcolepsy's pathology.

The genetic pathway--involving a neuropeptide called orexin or hypocretin, and its receptor gene--was identified in two, nearly simultaneous, publications in Cell. A group at Stanford University discovered the receptor gene, and a group at University of Texas Southwestern Medical Center discovered the ligand gene. "The papers essentially confirmed one another. That's very important. It's rare to get an instant confirmation of a finding like this," says psychiatrist Emmanuel Mignot, of the Center for Narcolepsy at Stanford University School of Medicine and the senior investigator on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies